Actions, AD/CVD cases, ITC investigations, hearings, OFAC actions, and HTS codes. No account required.
Type at least 2 characters to search the public source record.
Trade-policy analysis for import-scope decisions, written from the public record. Start from a product line, origin, supplier, or case, then read what the record changes for that file.
U.S. lawmakers want PACA-style protection for produce exports to Mexico. The test is whether sellers can claim the money after the buyer resells the goods.
The Chinese car ban bill would tie some vehicle approvals to five years of U.S. manufacturing before enactment. New investment could not replace that history.
Mexico's expanding trade agenda makes the count of resolved issues a poor guide to tariff relief, even as specific reforms receive U.S. recognition.
Xi's September 24 investment appeal leaves a site-selection problem: the same Chinese-backed factory can face different CFIUS exposure on different parcels.
A Chinese ship-fee restart on the existing schedule would widen the cost gap between vessels with Chinese owners or operators and other Chinese-built ships.
Washington is weighing diesel supply relief. For foreign-flag coastal cargoes, the current Jones Act waiver makes voyage approval and loading dates decisive.
Higher German drug prices could reduce Medicaid's extra MFN rebates if they lift its international benchmark. The effect depends on price data and contract terms.
Mexico's aluminum monitor pairs U.S. product origin with foreign smelting, allowing separate tests of U.S. purchases and North American metal sourcing.
A Belarus potash deal could diversify U.S. sourcing by reallocating existing output, leaving buyers to test how much Canadian supply a firm offer can replace. The 2027 contract comparison needs volume, delivery terms and a common price basis.
A Chinese tariff cut could reduce U.S. medical-device prices while a 20% domestic-product preference still shapes government tender comparisons.